IP Library Granted Patent US 9,926,595
Granted Patent B2
US 9,926,595 · App. 15/466,237 · Granted Mar 27, 2018

Methods and solutions for inhibiting undesired cleaving of labels

Inventors: Jerzy Olejnik (Brookline, MA); Evan Guggenheim (Brookline, MA); Visalakshi Meyyappan (Ashland, MA)
Assignee: INTELLIGENT BIO-SYSTEMS, INC.
C12Q1/6869C12Q1/6806C12Q1/6825G06F19/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,926,595
App. No.
15/466,237
Granted
Mar 27, 2018
Kind
B2
Abstract

The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. The methods of the invention include correcting one or more phenomena that are encountered during nucleotide sequencing, such as using sequencing by synthesis methods. These phenomena include, without limitation, sequence lead, sequence lag, spectral crosstalk, and noise resulting from variations in illumination and/or filter responses.

Claims (10)

1. A method of incorporating labeled nucleotides into nucleic acid, comprising: a) providing a plurality of nucleic acid template molecules, a polymerase, a cleaving agent, a cleaving agent scavenger, and a plurality of nucleotide analogues wherein each nucleotide analogue is labeled with a unique label attached through a cleavable disulfide linker and contains a removable chemical moiety capping the 3′-OH group, wherein said removable chemical moiety comprises a disulfide bond; b) incorporating a first nucleotide analogue with said polymerase; c) detecting the label of the incorporated nucleotide analogue; d) removing the unique label and the chemical moiety of the incorporated nucleotide analogue capping the 3′-OH group with said cleaving agent; and e) introducing said cleaving agent scavenger under conditions such that it reacts with any leftover cleaving agent.

2. The method of claim 1 , wherein said cleaving agent is a phosphine.

3. The method of claim 2 , wherein said phosphine is Tris(2-carboxy-ethyl)phosphine.

4. The method of claim 1 , wherein said cleaving agent scavenger does not contain a nucleic acid base.

5. The method of claim 1 , further comprising, prior to step b) hybridizing a primer to said plurality of nucleic acid template molecules, such that said first nucleotide analogue is incorporated into said primer at step b).

6. A method of incorporating labeled nucleotides into nucleic acid, comprising: a) providing a plurality of nucleic acid template molecules, a polymerase, a cleaving agent, a cleaving agent scavenger, and a plurality of nucleotide analogues selected from the group consisting of cytosine, thymine, deaza-adenine and deaza-guanine, wherein each nucleotide analogue comprises a unique label attached through a cleavable disulfide linker to a 5-position of cytosine or thymine or to a 7-position of deaza-adenine or deaza-guanine, and wherein each nucleotide analogue contains a removable chemical moiety capping the 3′-OH group, wherein said removable chemical moiety comprises a disulfide bond; b) incorporating a first nucleotide analogue with said polymerase; c) detecting the label of the incorporated nucleotide analogue; d) removing the chemical moiety of the incorporated nucleotide analogue capping the 3′-OH group and cleaving the cleavable linker with said cleaving agent; and e) introducing said cleaving agent scavenger under conditions such that it reacts with any leftover cleaving agent.

7. The method of claim 6 , further comprising, prior to step b) hybridizing a primer to said plurality of nucleic acid template molecules, such that said first nucleotide analogue is incorporated into said primer at step b).

8. The method of claim 6 , wherein said cleaving agent is a phosphine.

9. The method of claim 8 , wherein said phosphine is Tris(2-carboxy-ethyl)phosphine.

10. The method of claim 6 , wherein said cleaving agent scavenger does not contain a nucleic acid base.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2023
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: ISOPLEXIS CORPORATION
Reel/Frame 063235/0942 →
PATENT PURCHASE AGREEMENT Recorded Jul 30, 2021
From: QIAGEN SCIENCES, LLC
To: ISOPLEXIS CORPORATION
Reel/Frame 057043/0629 →
SECURITY AGREEMENT Recorded May 28, 2021
From: ISOPLEXIS CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 056421/0929 →
MERGER Recorded Nov 8, 2018
From: QIAGEN WALTHAM, INC.
To: QIAGEN SCIENCES, LLC
Reel/Frame 047923/0815 →
CHANGE OF NAME Recorded May 17, 2018
From: INTELLIGENT BIO-SYSTEMS, INC.
To: QIAGEN WALTHAM, INC.
Reel/Frame 047132/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2017
From: OLEJNIK, JERZY; GUGGENHEIM, EVAN; MEYYAPPAN, VISALAKSHI
To: INTELLIGENT BIO-SYSTEMS, INC.
Reel/Frame 042327/0942 →
Continuity (4)
Continuation 14456321 · Aug 11, 2014
Continuation 12405925 · Mar 17, 2009
Provisional Application 61037845 · Mar 19, 2008
Related Publication 20170275671A1 · Sep 28, 2017